COLANERI, MARTA
 Distribuzione geografica
Continente #
AS - Asia 4.556
NA - Nord America 4.028
EU - Europa 2.995
SA - Sud America 531
AF - Africa 118
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 3
Totale 12.245
Nazione #
US - Stati Uniti d'America 3.860
SG - Singapore 1.481
CN - Cina 1.313
IT - Italia 1.198
HK - Hong Kong 533
VN - Vietnam 423
BR - Brasile 415
RU - Federazione Russa 312
DE - Germania 252
NL - Olanda 237
GB - Regno Unito 208
IN - India 196
FR - Francia 187
BD - Bangladesh 162
FI - Finlandia 143
SE - Svezia 137
CA - Canada 91
ID - Indonesia 77
TR - Turchia 71
IE - Irlanda 65
ES - Italia 61
KR - Corea 60
CI - Costa d'Avorio 57
JP - Giappone 49
MX - Messico 46
AR - Argentina 39
PL - Polonia 37
AT - Austria 35
PK - Pakistan 26
IQ - Iraq 25
UA - Ucraina 23
PH - Filippine 22
CH - Svizzera 20
CO - Colombia 19
ZA - Sudafrica 19
EC - Ecuador 18
SA - Arabia Saudita 15
CL - Cile 13
MY - Malesia 13
AU - Australia 11
BE - Belgio 11
CZ - Repubblica Ceca 10
IR - Iran 10
UZ - Uzbekistan 10
GR - Grecia 9
IL - Israele 9
VE - Venezuela 9
AE - Emirati Arabi Uniti 8
EG - Egitto 8
TW - Taiwan 8
DK - Danimarca 7
KE - Kenya 7
RO - Romania 7
JM - Giamaica 6
JO - Giordania 6
MA - Marocco 6
AZ - Azerbaigian 5
CR - Costa Rica 5
HU - Ungheria 5
KG - Kirghizistan 5
PY - Paraguay 5
UY - Uruguay 5
AL - Albania 4
DZ - Algeria 4
KZ - Kazakistan 4
LT - Lituania 4
PA - Panama 4
PE - Perù 4
SI - Slovenia 4
TN - Tunisia 4
AM - Armenia 3
BO - Bolivia 3
HR - Croazia 3
NG - Nigeria 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
PS - Palestinian Territory 3
PT - Portogallo 3
SC - Seychelles 3
SN - Senegal 3
SV - El Salvador 3
TH - Thailandia 3
BB - Barbados 2
BY - Bielorussia 2
CU - Cuba 2
HN - Honduras 2
LK - Sri Lanka 2
LV - Lettonia 2
PR - Porto Rico 2
TJ - Tagikistan 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BG - Bulgaria 1
BH - Bahrain 1
CY - Cipro 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
Totale 12.225
Città #
Dallas 851
Singapore 729
Ashburn 524
Hong Kong 421
San Jose 347
Hefei 324
Milan 324
Council Bluffs 211
Los Angeles 182
Beijing 160
Ho Chi Minh City 146
New York 119
Santa Clara 104
Bengaluru 90
Hanoi 89
Southend 79
Lauterbourg 78
Rome 69
Moscow 68
Munich 67
Buffalo 66
Dublin 66
Chandler 64
Guangzhou 64
Helsinki 60
Chicago 58
Frankfurt am Main 58
Abidjan 57
Jakarta 57
São Paulo 57
Seoul 49
Istanbul 48
Lappeenranta 47
Boardman 45
The Dalles 44
Tokyo 38
Hanover 35
Nuremberg 35
Cangzhou 34
Fairfield 34
Turku 34
Shanghai 31
Da Nang 30
Houston 30
Atlanta 28
Montreal 27
Redwood City 26
Toronto 26
Bodio Lomnago 24
Warsaw 23
Phoenix 22
Amsterdam 21
Chennai 21
Denver 21
Princeton 21
Seattle 21
London 20
Wilmington 20
Columbus 19
Orem 19
Poplar 19
Salt Lake City 19
San Francisco 19
Washington 19
Mexico City 18
Haiphong 17
Pavia 17
Woodbridge 17
Stockholm 16
Vienna 16
Shenzhen 15
Florence 14
Silver Spring 14
Dong Ket 13
Mumbai 13
Turin 12
Brooklyn 11
Johannesburg 11
Madrid 11
Naples 11
Piscataway 11
Rio de Janeiro 11
Tianjin 11
Baghdad 10
Brasília 10
Curitiba 10
Palosco 10
Bexley 9
Bologna 9
Boston 9
Cambridge 9
Dhaka 9
Fuzhou 9
Paris 9
Tashkent 9
Zurich 9
Ann Arbor 8
Chengdu 8
Chongqing 8
Des Moines 8
Totale 6.970
Nome #
SARS Cov-2 infection in a renal-transplanted patient: A case report 546
Clinical characteristics of coronavirus disease (COVID-19) early findings from a teaching hospital in Pavia, North Italy, 21 to 28 February 2020 388
The impact of SARS-CoV-2 VOCs on clinical outcomes: an overview of reviews 382
Incidence, microbiology, and mortality of ventilation-associated pneumonia in a large Italian cohort of critically ill patients: results from the PROSAFE project 363
Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy 357
Lack of SARS-CoV-2 RNA environmental contamination in a tertiary referral hospital for infectious diseases in Northern Italy 314
A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death 304
Exploring early COVID-19 therapies, variants, and viral clearance dynamics: Insights from a high-risk outpatients study 251
Prevalence of extracardiac vascular complications in Abiotrophia spp. and Granulicatella spp. infective endocarditis: Two case reports and a systematic review 249
Emergency Department and Out-of-Hospital Emergency System (112-AREU 118) integrated response to Coronavirus Disease 2019 in a Northern Italy centre 236
EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count 204
High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life setting 202
Reduction of BSI associated mortality after a sepsis project implementation in the ER of a tertiary referral hospital 192
Epidemiology, Clinical Manifestations, and Outcome of Mucormycosis in Solid Organ Transplant Recipients: A Systematic Review of Reported Cases 176
Epidemiology and Clinical Insights of Catheter-Related Candidemia in Non-ICU Patients with Vascular Access Devices 176
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients 172
The impact of COVID-19 hospitalizations on nursing home admissions: a regional insight into long-term care and public health 170
Early administration of nirmatrelvir/ritonavir leads to faster negative SARS-CoV-2 nasal swabs than monoclonal antibodies in COVID 19 patients at high-risk for severe disease 169
Vascular Access Device Infections: Current Management Practices and the Role of Multidisciplinary Teams at a Large Hospital in Northern Italy 169
Therapeutic Drug Monitoring of Dalbavancin in Real Life: A Two-Year Experience 162
From Colonisation to Infection: Assessing the BSI Potential in Patients with KPC, NDM, VRE and CRAB Rectal Colonisation 161
A worldwide survey on perioperative antimicrobial prophylaxis for heart transplantation: From theory to clinical practice 149
Proactive therapeutic monitoring of dalbavancin concentrations in the long-term management of chronic osteoarticular/periprosthetic joint infections 148
Predictors of starting antimicrobial treatment in patients with nontuberculous mycobacterial lung disease in the Italian scenario: a SITA GIOVANI-IRENE promoted web-survey 148
Carbapenem or new β-lactam-β-lactamase inhibitors? An Italian survey supported by SITA, SIMIT and SIAARTI to identify the factors affecting empiric antimicrobial therapy choice in real-life clinical practice 145
Understanding the burden of antibiotic resistance: a decade of carbapenem-resistant Gram-negative bacterial infections in Italian intensive care units 145
A multi-centre study in Northern Italy to evaluate the impact of a Sepsis bundle in Obstetric Settings: the SOS study 143
Exploring post-SEPSIS and post-COVID-19 syndromes: crossovers from pathophysiology to therapeutic approach 137
Major Bleeding Events in Hospitalized COVID-19 Patients: A Retrospective Observational Study 137
Mismanagement of SARS-CoV-2 Infection Pre Hospitalisation during the Omicron Era: Antibiotics and Steroids Instead of Early Antivirals 135
Ventilator-Associated Pneumonia Due to MRSA vs. MSSA: What Should Guide Empiric Therapy? 134
Application of Artificial Intelligence in Inborn Errors of Immunity Identification and Management: Past, Present, and Future—A Systematic Review 132
Prognostic Significance of NLR and PLR in COVID-19: A Multi-Cohort Validation Study 130
Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6-8 months after the infection 126
Modelling the COVID-19 epidemic and implementation of population-wide interventions in Italy 124
Assessing the prevalence of schistosomiasis and strongyloidiasis in a tuberculosis clinic: the TB-TROPIcare study 121
Implementation of an antimicrobial stewardship program in the Vascular Surgery ward of a university tertiary care hospital in Pavia, Northern Italy 120
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy 119
Immunity to SARS-CoV-2 up to 15 months after infection 119
Patients with chronic hepatitis C receiving treatment with direct acting antivirals: How is this population changing? 117
Impact of Early Antiviral Therapy on SARS-CoV-2 Clearance Time in High-Risk COVID-19 subjects: A Propensity Score Matching Study 115
Impact of Pneumococcal Urinary Antigen Testing in COVID-19 Patients: Outcomes from the San Matteo COVID-19 Registry (SMACORE) 115
Rifampicin drug monitoring in TB patients: new evidence for increased dosage? 115
Are people previously infected with SARS-CoV-2 likely to experience COVID-19 symptoms again after vaccination? Results from an Italian COVID-19 referral center 114
Early remdesivir to prevent severe COVID-19 in recipients of solid organ transplant: a real-life study from Northern Italy 114
Dynamic NLR and PLR in Predicting COVID-19 Severity: A Retrospective Cohort Study 114
Mortality of Patients With Candidemia and COVID-19: A Systematic Review With Meta-analysis 112
Ultra-rare RTEL1 gene variants associate with acute severity of COVID-19 and evolution to pulmonary fibrosis as a specific long COVID disorder 111
The CONSIDER study: Assessing the risk of catheter-associated bloodstream infections beyond the intensive care setting 109
An eight-year experience of Nocardia infection in Italy: does immunosuppression matter? 106
Severe acute respiratory syndrome coronavirus 2 RNA contamination of inanimate surfaces and virus viability in a health care emergency unit 103
Discordant Liver Fibrosis Predictors in Virologically Suppressed People Living with HIV without Hepatitis Virus Infection 102
An explainable model of host genetic interactions linked to COVID-19 severity 100
Appropriateness of loading dose and TDM in patients treated with teicoplanin: a single-centre observational retrospective cohort study comparing single-daily and thrice-weekly regimens 100
Assessing the Efficacy of Early Therapies against SARS-CoV-2 in Hematological Patients: A Real-Life Study from a COVID-19 Referral Centre in Northern Italy 100
What prompts clinicians to start antibiotic treatment in COVID-19 patients? An Italian web survey helps us to understand where the doubts lie 99
Response to the Letter to the Editor Regarding “Prognostic Significance of NLR and PLR in COVID-19: A Multi-Cohort Validation Study” 99
Is a radiological score needed to define the severity of Nontuberculous mycobacteria lung disease? 97
Exploring Human Use of Monoclonal Antibodies Against Critical Bacteria: A Scoping Review of Clinical Trials 97
HBV and HDV: New Treatments on the Horizon 97
Proactive Therapeutic Drug MONiToring to Guide Suppressive Antibiotic Therapy with DALBAvaNcin ( > 12 weeks) in Osteoarticular Infections (MONTALBANO) 93
Daptomycin Pharmacokinetics and Pharmacodynamics in Patients on Methadone Substitution Therapy 90
Mortality due to COVID-19 during the pandemic: A comparison of first, secondo and third SMAtteo COvid19 REgistry (SMACORE) 89
Impaired respiratory function reduces haemoglobin oxygen affinity in COVID-19 87
COVID vaccination and asthma exacerbation: might there be a link? 86
The experience of the health care workers of a severely hit SARS-CoV-2 referral Hospital in Italy: incidence, clinical course and modifiable risk factors for COVID-19 infection 86
SARS-CoV-2 specific T-cell immunity in COVID-19 convalescent patients and unexposed controls measured by ex vivo ELISpot assay 85
Real-life lack of evidence of viable SARS-CoV-2 transmission via inanimate surfaces: The SURFACE study 84
Primary Spinal Epidural Abscesses Not Associated With Pyogenic Infectious Spondylodiscitis: A New Pathogenetic Hypothesis 83
Use of a molecular syndromic panel for the etiological diagnosis of ventilator-associated bacterial pneumonia: impact on clinical outcomes and antibiotic use from a multicenter, prospective study 80
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 80
Pharmacokinetic profile of dolutegravir after transjugular intrahepatic portosystemic shunt placement 79
Modeling vaccination rollouts, SARS-CoV-2 variants and the requirement for non-pharmaceutical interventions in Italy 78
Serum and breastmilk SARS-CoV-2 specific antibodies following BNT162b2 vaccine: prolonged protection from SARS-CoV-2 in newborns and older children 77
Predictors of COVID-19 Readmission Among Patients Previously Hospitalized for SARS-CoV-2 75
Solid organ transplant in recipients with ongoing SARS-CoV-2 infection: A systematic review of case reports and series 74
Optimizing antibiotic therapy for intravenous drug users: a narrative review unraveling pharmacokinetics/pharmacodynamics challenges 73
Tocilizumab for Treatment of Severe COVID-19 Patients: Preliminary Results from SMAtteo COvid19 REgistry (SMACORE) 72
The WEST Study: A Retrospective and Multicentric Study on the Impact of Steroid Therapy in West Nile Encephalitis 71
Funnel-based antimicrobial resistance monitoring in Italy: the FUN-IT study 71
Burden and Outcomes of Severe Lower Respiratory Tract Infections with Unknown Etiology: A Retrospective Observational Study on Epidemiological Trends Over an 8-Year Period (2016-2024) 70
Specialist Healthcare Intervention and Follow-up Trends in Post-Acute COVID-19 Hospitalization as Compared to Other Respiratory Infections 70
Despite Vaccination: A Real-Life Experience of Severe and Life-Threatening COVID-19 in Vaccinated and Unvaccinated Patients 69
The obesity paradox: Analysis from the SMAtteo COvid-19 REgistry (SMACORE) cohort 68
Cryptococcosis in an HIV-negative, HCV positive, immunosenescent patient: a case report 68
Corrigendum: Understanding the burden of antibiotic resistance: a decade of carbapenem-resistant Gram-negative bacterial infections in Italian intensive care units 66
The infection risk after transjugular intrahepatic portosystemic shunt: A multiple competing risk analysis from a tertiary care center 64
Rapid response to COVID-19 outbreak in Northern Italy: how to convert a classic infectious disease ward into a COVID-19 response centre 61
Early detection of variants of concern via funnel plots of regional reproduction numbers 59
Hospital Acquired Infections Among Solid Organ Transplant Recipients Hospitalized in Intensive Care Unit (2018-2024): A Study of the GiViTI Group 57
Culture negative endocarditis and the role of proper blood culture collection: results from a tertiary care Centre of Northern Italy 56
Competing-risk analysis of coronavirus disease 2019 in-hospital mortality in a Northern Italian centre from SMAtteo COvid19 REgistry (SMACORE) 52
A case of Corynebacterium striatum endocarditis successfully treated with an early switch to oral antimicrobial therapy 51
Risk factors associated with mortality in patients with catheter-related and catheter-associated bloodstream infections: a retrospective observational study focused on CVADs and midlines 46
Low risk of SARS-CoV-2 transmission by fomites in real-life conditions 44
Running out of bullets: The challenging management of acute hepatitis and SARS-COV-2 from the SMatteo COvid19 Registry (SMACORE) 39
A challenging case of SARS-CoV-2- AIDS and Nocardiosis coinfection from the SMatteo COvid19 REgistry (SMACORE) 39
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity 29
Proximity extension assay-based targeted proteomics for biomarker discovery in adult bacterial infections 13
Integrating artificial intelligence with genome sequencing against antimicrobial resistance: a narrative review 13
Totale 12.638
Categoria #
all - tutte 33.034
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.034


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202169 0 0 0 0 0 0 0 0 0 0 31 38
2021/2022332 29 30 23 14 23 14 27 37 41 29 18 47
2022/2023266 27 31 20 27 31 38 7 12 40 5 21 7
2023/2024295 6 17 20 7 38 13 10 6 8 24 59 87
2024/20253.289 286 258 97 230 208 158 145 277 171 408 362 689
2025/20267.975 590 1.121 1.066 804 647 376 914 439 680 607 731 0
Totale 12.669